GlassScriptPhysician profile
Korboi Evans
NPI 1063611663
$22,996.07
in general payments reported to CMS, 2019-2025
25 companies · $17K in 2025
The $17K reported for 2025 was more than what 90% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,125 · 2020: $1,336 · 2021: $532 · 2022: $964 · 2023: $833 · 2024: $945 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Food and Beverage: $3,184 · Travel and Lodging: $920.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,935.00 |
| Food and Beverage | $3,184.30 |
| Travel and Lodging | $920.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $18,533.98 | 2019-2025 | Zipseal 16 Surgical Skin Closure Kit, System 9 Cd Nxt, Zipseal 24 Surgical Skin Closure Kit |
| Zimmer Biomet Holdings, INC. | $1,250.57 | 2019-2021 | |
| Abbott Laboratories | $546.97 | 2019-2024 | Proclaim |
| Amgen INC. | $377.98 | 2021-2025 | Evenity, Prolia, Krystexxa |
| Ferring Pharmaceuticals INC. | $327.83 | 2019-2025 | Euflexxa |
| Biotissue Holdings INC. | $259.82 | 2022 | |
| Baxter Healthcare | $230.50 | 2024-2025 | Floseal, Tisseel |
| Depuy Synthes Sales INC. | $179.16 | 2019-2024 | Emphasys, Trumatch |
| Globus Medical, INC. | $150.00 | 2021 | |
| Si-Bone, INC. | $144.92 | 2021 | |
| Biocomposites INC | $132.27 | 2025 | Stimulan |
| Pacira Pharmaceuticals Incorporated | $111.39 | 2023-2025 | Zilretta, Exparel, Iovera |
| Arthrex, INC. | $110.90 | 2021 | |
| Innovation Technologies INC | $110.08 | 2023 | Irrisept |
| Acell, INC. | $100.20 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $94.87 | 2024 | Intellis Adaptivestim |
| Vericel Corporation | $69.73 | 2023-2024 | Maci |
| Smith+Nephew, INC. | $67.85 | 2019-2025 | Pico 7 |
| Horizon Therapeutics Plc | $33.81 | 2019-2022 | |
| Pacira Therapeutics, INC. | $33.01 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $32.98 | 2022 | |
| Fidia Pharma USA INC. | $32.73 | 2019-2024 | Hymovis |
| Mimedx Group, INC. | $22.58 | 2025 | |
| Bioventus LLC | $21.64 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $20.30 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Korboi Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.